Global Diagnostic Radiopharmaceuticals Market Insights and Forecast to 2031

Report ID: 888158 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Diagnostic Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Technetium 99
Fluorine 18
Other
Diagnostic radiopharmaceuticals are mainly divided into technetium 99, fluorine 18 and others. Among them, technetium 99 accounted for the main part, accounting for about 47.56% of the total market in 2019.

Segment by Application
Oncology
Cardiology
Other
Diagnostic radiopharmaceutical applications are mainly for oncology, cardiology and others. Among them, oncology accounts for the main part, accounting for about 45.8% of the total market in 2019.

By Company
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia

Frequently Asked Questions
Diagnostic Radiopharmaceuticals report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diagnostic Radiopharmaceuticals report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diagnostic Radiopharmaceuticals report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Mesotherapy

Mesotherapy market is segmented by Type, and by Application. Players, stakeholders, and other par ... Read More